Earnings Call · Q2 FY2021·2021-07-21

Q2 21EPS +10.88%·Rev n/aQ1 21EPS +8.35%·Rev n/aQ4 20EPS +0.40%·Rev n/aQ3 20EPS +0.48%·Rev n/a⚠ consensus missing

Elevance Health, Inc. ELV

Stephen Tanal — Vice President of Investor Relations

Gail Boudreaux — President and Chief Executive Officer (CEO)

John Gallina — Chief Financial Officer (CFO)

−1.6%1d on move date−2.4% vs SPY3d−2.0%5d−1.9%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ELV calls or request research access.

More ELV calls Browse calls Request research access